LXEO
Lexeo Therapeutics, Inc.
3.30$
-2.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| -604.3% | -2,666.4% | -8,342.5% | – | – | – | |
| 0.0% | 0.8% | 175.1% | – | – | – | |
| 0.0% | 23.3% | 272.3% | – | – | – | |
| 29.0% | 364.6% | 273.9% | – | – | – | |
| 0.0% | 11.3% | 137.8% | – | – | – | |
| – | -11.3% | -137.8% | – | – | – | |
| – | 0.0% | -24.9% | – | – | – | |
| 6,245.0% | 9,104.2% | 28.9% | – | – | – | |
| 5,640.6% | 6,426.5% | -8,451.4% | – | – | – | |
| -604.3% | -2,677.7% | -8,480.3% | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.